Instem plc Issue of Equity and Total Voting Rights (4338R)
February 28 2019 - 4:35AM
UK Regulatory
TIDMINS
RNS Number : 4338R
Instem plc
28 February 2019
Instem plc
("Instem" or the "Company")
Issue of Equity and Total Voting Rights
Instem plc (AIM: INS), a leading provider of IT solutions to the
global life sciences market, announces that, following the exercise
of share options, 93,713 new ordinary shares of 10p each in the
Company ("Ordinary Shares") have been issued.
Application will be made to the London Stock Exchange for the
admission of the 93,713 new Ordinary Shares to trading on AIM ("New
Ordinary Shares"). Admission is expected to take place at 8.00 a.m.
on 6 March 2019.
Total Voting Rights
Following the issue and allotment of the above New Ordinary
Shares, the Company's issued share capital will comprise 16,246,983
Ordinary Shares. The Company does not hold any Ordinary Shares in
treasury. Therefore the total number of voting rights in the
Company will be 16,246,983.
The figure of 16,246,983 may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change of their
interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
For further information, please contact:
Instem plc +44 (0) 1785 825 600
Phil Reason, CEO
Nigel Goldsmith, CFO
N+1 Singer (Nominated Adviser
& Broker) +44 (0) 20 7496 3000
Richard Lindley, Corporate Finance
Rachel Hayes, Corporate Broking
Walbrook Financial PR
Paul Cornelius +44 (0) 20 7933 8780
Sam Allen instem@walbrookpr.com
Nick Rome
About Instem
Instem is a leading provider of IT solutions & services to
the life sciences market delivering compelling solutions for Study
Management and Data Collection; Regulatory Solutions for
Submissions and Compliance; and Informatics-based Insight
Generation.
Instem solutions are in use by customers worldwide and enable
our clients to bring life enhancing products to market faster.
Instem's portfolio of software solutions increases client
productivity by automating study-related processes while offering
the unique ability to generate new knowledge through the extraction
and harmonisation of actionable scientific information.
Instem supports over 500 clients through offices in the United
States, United Kingdom, France, Japan, China and India.
To learn more about Instem solutions and its mission, please
visit instem.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCEAEAPADANEFF
(END) Dow Jones Newswires
February 28, 2019 05:35 ET (10:35 GMT)
Instem (LSE:INS)
Historical Stock Chart
From Apr 2024 to May 2024
Instem (LSE:INS)
Historical Stock Chart
From May 2023 to May 2024